Class I antigen presentation
Jelachich, M.L.; Biddison, W.E.
Year in Immunology 4: 41-58
1989
ISSN/ISBN: 0256-2308 PMID: 2522701 Document Number: 334673
Document emailed within 1 workday
Related Documents
Dang, L.H.; Lien, L.L.; Benacerraf, B.; Rock, K.L. 1993: A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation Journal of Immunology 150(10): 4206-4217Charreau, B.; Coupel, S.; Boulday, G.; Soulillou, J.P. 2000: Cyclosporine inhibits class II major histocompatibility antigen presentation by xenogeneic endothelial cells to human T lymphocytes by altering expression of the class II transcriptional activator gene Transplantation 70(2): 354-361
Brooks, A.G.; McCluskey, J. 1993: Class II-restricted presentation of a hen egg lysozyme determinant derived from endogenous antigen sequestered in the cytoplasm or endoplasmic reticulum of the antigen presenting cells Journal of Immunology 150(9): 3690-3697
Freed, J.H.; Rosloniec, E.F. 1988: Molecular aspects of the role of class II MHC molecules in antigen presentation to T cells Year in Immunology 3: 161-178
Pinet, V.; Malnati, M.S.; Long, E.O. 1994: Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen Journal of Immunology 152(10): 4852-4860
Lehmann-Grube, F.; Dralle, H.; Utermöhlen, O.; Löhler, J. 1994: MHC class I molecule-restricted presentation of viral antigen in beta 2-microglobulin-deficient mice Journal of Immunology 153(2): 595-603
St-Pierre, Y.; Watts, T.H. 1990: MHC class II-restricted presentation of native protein antigen by B cells is inhibitable by cycloheximide and brefeldin A Journal of Immunology 145(3): 812-818
Laufer, T.M.; Smiley, S.T.; Ranger, A.; Clements, V.K.; Ostrand-Rosenberg, S.; Glimcher, L.H. 1997: Single amino acid mutations in the murine MHC class II A beta cytoplasmic domain abrogate antigen presentation Journal of Immunology 159(12): 5914-5920
Lang, G.A.; Lang, M.L. 2006: Protein kinase Balpha is required for vesicle trafficking and class II presentation of IgA Fc receptor (CD89)-targeted antigen Journal of Immunology 176(7): 3987-3994
Swier, K.; Miller, J. 1995: Invariant chain-independent antigen presentation depends primarily upon the pool of newly synthesized MHC class II molecules Journal of Immunology 155(4): 1851-1861
Kandil, E.; Namikawa, C.; Nonaka, M.; Greenberg, A.S.; Flajnik, M.F.; Ishibashi, T.; Kasahara, M. 1996: Isolation of low molecular mass polypeptide complementary DNA clones from primitive vertebrates. Implications for the origin of MHC class I-restricted antigen presentation Journal of Immunology 156(11): 4245-4253
Ostrand-Rosenberg, S.; Roby, C.A.; Clements, V.K. 1991: Abrogation of tumorigenicity by MHC class Ii antigen expression requires the cytoplasmic domain of the class Ii molecule Journal of Immunology 147(7): 2419-2422
Shinohara, N.; Hozumi, N.; Watanabe, M.; Bluestone, J.A.; Johnson-Leva, R.; Sachs, D.H. 1988: Class Ii antigen-specific murine cytolytic T lymphocytes (CTL). II. Genuine class Ii specificity of Lyt-2+ CTL clones Journal of Immunology 140(1): 30-36
Azuma, T.; Sato, S.; Kitagawa, S.; Hori, S.; Kokudo, S.; Hamaoka, T.; Fujiwara, H. 1989: Tolerance induction of allo-class i H-2 antigen-reactive Lyt-2+ helper T cells and prolonged survival of the corresponding class i H-2-disparate skin graft Journal of Immunology 143(1): 1-8
Kalovidouris, A.E. 1992: The role of cytokines in polymyositis: interferon-gamma induces class Ii and enhances class i major histocompatibility complex antigen expression on cultured human muscle cells Journal of Laboratory and Clinical Medicine 120(2): 244-251
Garson, D.; Dokhélar, M.C.; Wakasugi, H.; Mishal, Z.; Tursz, T. 1985: HLA class-i and class-Ii antigen expression by human leukemic K562 cells and by Burkitt-K562 hybrids: modulation by differentiation inducers and interferon Experimental Hematology 13(9): 885-890
Squire, C.M.; Studer, E.J.; Lees, A.; Finkelman, F.D.; Conrad, D.H. 1994: Antigen presentation is enhanced by targeting antigen to the Fc epsilon RII by antigen-anti-Fc epsilon RII conjugates Journal of Immunology 152(9): 4388-4396
Al-Alwan, M.M.; Okkenhaug, K.; Vanhaesebroeck, B.; Hayflick, J.S.; Marshall, A.J. 2007: Requirement for phosphoinositide 3-kinase p110delta signaling in B cell antigen receptor-mediated antigen presentation Journal of Immunology 178(4): 2328-2335
Kawano, Y.; Yoshizawa, I.; Baba, M.; Noma, T. 1996: Ketotifen inhibits allergen-specific T lymphocytes' responses by suppressing antigen presentation with concomitant decrease of HLA-DQ antigen on macrophages Asian Pacific Journal of Allergy and Immunology 14(2): 69-79
Mannhalter, J.W.; Neychev, H.O.; Zlabinger, G.J.; Ahmad, R.; Eibl, M.M. 1985: Modulation of the human immune response by the non-toxic and non-pyrogenic adjuvant aluminium hydroxide: effect on antigen uptake and antigen presentation Clinical and Experimental Immunology 61(1): 143-151